StoneCrest Wealth Management »

Miragen Therapeutics shares owned by StoneCrest Wealth Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by StoneCrest Wealth Management from 13F filings

Historical chart of StoneCrest Wealth Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by StoneCrest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by StoneCrest Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $485k 28k 17.51
2023-12-31 $605k 28k 21.78

More positions owned by StoneCrest Wealth Management

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Semiconductr Etf (SMH)
First Tr Nas100 Eq Weighted SHS (QQEW)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Global X Fds S&p 500 Covered (XYLD)
Apple (AAPL)
Wisdomtree Tr Cloud Computng (WCLD)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for StoneCrest Wealth Management

Top funds holding Miragen Therapeutics

Paradigm Biocapital Advisors
VR Adviser
Vanguard Group
Maverick Capital
Alliancebernstein
Commodore Capital
Perceptive Advisors
Vivo Capital
Fairmount Funds Management
Yiheng Capital
Citadel Advisors
Tang Capital Management
Octagon Capital Advisors
Kynam Capital Management
Logos Global Management

View all funds holding Miragen Therapeutics